Glycohemoglobins and glucose tolerance

Area of Science:

• Clinical Chemistry
• Endocrinology
• Diabetes Mellitus Research

Background:

• Glycohemoglobin (GHb) is a key indicator of long-term glycemic control.
• Assessing GHb alongside glucose tolerance tests (GTT) can refine diabetes diagnosis and management.

Purpose of the Study:

• To evaluate the utility of glycohemoglobin (GHb) assay in conjunction with glucose tolerance tests (GTT).
• To establish correlations between GHb levels and glycemic control in diabetic and non-diabetic individuals.

Main Methods:

• Glycohemoglobin (GHb) levels were determined using chromatography on weakly acidic acrylic cationite columns.
• Assays were performed on 167 patients undergoing GTT and 105 known diabetics.

Main Results:

• In patients with normal GTT, 95% had GHb levels between 6.8% and 9.8%.
• GHb levels were normal in latent diabetes and elevated in poorly controlled diabetes.
• GHb correlated positively with fasting plasma glucose and GTT values, significantly in non-insulin-treated patients.
• GHb levels effectively distinguished between latent and overt diabetes, reflecting glycemic control.

Conclusions:

• Glycohemoglobin (GHb) assay is a valuable tool for assessing glycemic control and differentiating diabetes severity.
• GHb levels provide a reliable correlation with fasting plasma glucose and glucose tolerance test results.
• Monitoring GHb is crucial for tracking diabetes management and treatment efficacy.